Companies / MediWound
MediWound
Company
MediWound develops and delivers next-generation enzymatic treatments for non-surgical tissue repair, particularly for burns and chronic wounds.
MediWound has 4 investors on file, among them Clal Biotechnology Industries, Deep Insight and Israel Biotech Fund. Its site was last checked 6 Nov 2026: site answers.
Investors
4 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
In the news
1 headline naming MediWoundEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get MediWound and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Clal Biotechnology Industries adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/mediwound.com/investors
# also
GET /v1/companies/mediwound.com
GET /v1/companies/mediwound.com/news